Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma.

Koji SakamotoSatoru ItoNaozumi HashimotoYoshinori Hasegawa

Published in: BMC cancer (2017)

Pirfenidone, a novel oral agent with anti-inflammatory and -fibrotic properties, should be considered as a salvage drug for refractory cases of bleomycin-induced lung injury.

Keyphrases

pulmonary fibrosis
idiopathic pulmonary fibrosis
high glucose
diabetic rats
anti inflammatory
drug induced
emergency department
oxidative stress
systemic sclerosis
endothelial cells
combination therapy
replacement therapy